What are Tremors?
 

Tremors are an involuntary, rhythmic, oscillatory movement of one or more body parts, produced by alternating or synchronous contractions of antagonistic muscles.
 

• Resting Tremor: Occurs when the body part is completely supported against gravity and relaxed (e.g., hands resting passively in the lap). Typically diminishes or stops with voluntary movement.

• Action Tremor: Occurs during voluntary muscle contraction. Sub-classified into:

  • Postural Tremor: Present while maintaining a fixed posture against gravity (e.g., holding arms outstretched).

  • Kinetic Tremor: Present during any voluntary movement (e.g., moving a limb toward a target).

  • Intention Tremor: A specific, worsening kinetic tremor that amplifies as the target is approached (often associated with cerebellar pathology).

  • Task-Specific Tremor: Appears only during specific skilled activities (e.g., primary writing tremor).

Specific Types
 

Essential Tremor (ET)

• Presentation: The most common movement disorder, presenting primarily as a bilateral, symmetric action/postural tremor of the hands and forearms, and may involve the head or voice.

• Etiology: Strong genetic predisposition (familial tremor).
   

Parkinsonian Tremor

• Presentation: Resting tremor (occurs at rest), usually starts asymmetrically. Hand tremor may look like pill-rolling. May be accompanied by bradykinesia, rigidity, and postural instability.

• Etiology: Reduced of dopaminergic activity in the substantia nigra pars compacta within the basal ganglia.
   

Cerebellar Tremor

• Presentation: Coarse, low-frequency intention tremor associated with other signs of cerebellar dysfunction (ataxia, dysmetria, dysdiadochokinesia, and gait instability).

• Etiology: Stroke, multiple sclerosis, trauma, degenerative cerebellar disorders, or lesions affecting the cerebellum or its outflow pathways.
   

Enhanced Physiological Tremor

• Presentation: A high-frequency, low-amplitude postural/action tremor present in normal individuals but visibly amplified.

• Etiology: Sympathomimetic states (anxiety, fatigue, caffeine, alcohol or sedative withdrawal, hyperthyroidism, or drug-induced).
   

Functional (Psychogenic) Tremor

• Presentation: Abrupt onset, spontaneous remission, inconsistent frequency or amplitude, and characteristic entrainment (changing frequency when the contralateral limb performs a different rhythmic task).

Secondary Causes of Tremors
 

• Endocrine & Metabolic Alterations: Hyperthyroidism, hypoglycemia, hepatic encephalopathy, and severe electrolyte imbalances (hypocalcemia, hypomagnesemia).

• Toxins & Heavy Metal Poisoning: Mercury, lead, copper, arsenic, or chronic carbon monoxide poisoning.

• Substance Withdrawal: Acute alcohol or sedative withdrawal.

• Medication-Induced tremor: beta-agonists (albuterol), stimulants (amphetamines), psychotropics (lithium, valproic acid, antidepressants, antipsychotics​

Diagnostics
 

• Clinical History & Physical Examination: Detailed neurological exam assessing tremor characteristics (rest vs. action), frequency, symmetry, associated parkinsonian or cerebellar signs, family history, and complete medication/substance reconciliation.

• Laboratory Screening:

  • Thyroid-stimulating hormone (TSH) and free T4.

  • Comprehensive metabolic panel (renal/hepatic function, blood glucose, calcium, magnesium).

  • Serum ceruloplasmin and 24-hour urinary copper (to screen for Wilson's disease)

  • Toxicology screen if drug or toxin exposure is suspected.

• Advanced Diagnostics:

  • DaTscan (Ioflupane I 123 injection SPECT scan): Utilized to differentiate essential tremor (normal dopamine transporter binding) from parkinsonian syndromes (abnormal/reduced striatal binding).

  • Electrophysiological Testing (Tremorogram): Specialized accelerometer/electromyography (EMG) studies to measure exact tremor frequency and amplitude when clinical differentiation is difficult.

​
Management 
 

Non-Pharmacological Management
 

• Lifestyle & Dietary Modifications: Reducing or eliminating dietary stimulants (caffeine), moderating alcohol intake, managing anxiety, and addressing underlying sleep deprivation.

• Adaptive Devices & Ergonomics: Utilizing weighted utensils, heavy cups, wrist weights, and specialized writing tools to improve functional independence for activities of daily living (ADLs).

• Surgical & Procedural Interventions (for Refractory Cases): Deep Brain Stimulation (DBS) targeting the ventral intermediate (VIM) nucleus of the thalamus or focused ultrasound (MRgFUS) thalamotomy.

Pharmacological Management
 

• For Essential Tremor:

  • First-Line Agents: Propranolol (non-selective beta-blocker) or primidone (anticonvulsant).

  • Second-Line Agents: Topiramate, gabapentin, or alternative beta-blockers (e.g., nadolol, atenolol).

• For Parkinsonian Tremor:

  • Dopaminergic therapy (levodopa/carbidopa) or dopamine agonists, alongside anticholinergic agents (e.g., trihexyphenidyl) selectively utilized in younger patients with prominent tremor.

• For Enhanced Physiological / Anxious States:

  • Managing the underlying metabolic trigger, or utilizing beta-blockers on an as-needed basis for situational performance tremors.

                                                        References & Guidelines
 

• American Academy of Neurology (AAN). Evidence-Based Guideline Update: Treatment of Essential Tremor.

• International Parkinson and Movement Disorder Society (MDS). Consensus Statement on the Classification of Tremors.

• International Parkinson and Movement Disorder Society (MDS). Clinical Diagnostic Criteria for Parkinson's Disease.

• U.S. Food and Drug Administration (FDA). DaTscan (Ioflupane I-123) Prescribing Information.

• American Association for the Study of Liver Diseases (AASLD). Practice Guidance on Wilson Disease.